课题基金 / 基金详情

CLINICAL TRIAL: A RANDOMIZED DOSE-RESPONSE STUDY TO ASSESS THE SAFETY AND PRELIM

CLINICAL TRIAL: A RANDOMIZED DOSE-RESPONSE STUDY TO ASSESS THE SAFETY AND PRELIM
临床试验:评估安全性和初步效果的随机剂量反应研究
批准号:
7716568
负责人:
ROBIN K OHLS
金额:
$1.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-01 至 2008-11-30

项目摘要

项目成果

ROBIN K OHLS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. 1. To evaluate the effect of Darbepoietin on reticulocytes and hematocrits. 2. To estimate the rates of adverse events among very low birth weight (VLBW) infants who receive 1 of 3 doses of Darbepoietin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Darbepoetin Trial to Improve Red Cell Mass and Neurodevelopment in Preterms-CCC
  • 批准号:
    10152693
  • 项目类别:
  • 资助金额:
    $31.61万
  • 财政年份:
    2019
  • 负责人:
    ROBIN K OHLS
  • 依托单位:
Darbepoetin Trial to Improve Red Cell Mass and Neurodevelopment in Preterms-CCC
  • 批准号:
    9899664
  • 项目类别:
  • 资助金额:
    $36.0万
  • 财政年份:
    2019
  • 负责人:
    ROBIN K OHLS
  • 依托单位:
NICHD Cooperative Multicenter Neonatal Research Network - Utah Center
  • 批准号:
    9899864
  • 项目类别:
  • 资助金额:
    $28.14万
  • 财政年份:
    2016
  • 负责人:
    ROBIN K OHLS
  • 依托单位:
NICHD Cooperative Multicenter Neonatal Research Network - Utah Center
  • 批准号:
    10682083
  • 项目类别:
  • 资助金额:
    $34.49万
  • 财政年份:
    2016
  • 负责人:
    ROBIN K OHLS
  • 依托单位:
海外基金